An open-label extension study of the safety of long-term administration of sirolimus (Rapamune) in solid organ transplant recipients

Trial Profile

An open-label extension study of the safety of long-term administration of sirolimus (Rapamune) in solid organ transplant recipients

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Transplant rejection
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Aug 2009 Actual end date (1 Aug 2004) and actual patient number (769) added as reported by ClinicalTrials.gov.
    • 16 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top